The current control strategy relies on regular deworming with albendazole and improvements in water, sanitation, and hygiene.

In a phase 1 trial, eight out of 12 patients treated with different dosages of CTX112 responded to treatment ... which seems reasonable for a commercial-stage drugmaker with a next-generation blood ...

During a Case-Based Roundtable® event, Rahul Banerjee, MD, discussed approaches to dosing and tolerability when using ...